Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus.
We report a case of severe tracheobronchitis caused by methicillin-resistant Staphylococcus aureus in a man exhibiting symptoms of upper airway obstruction after infection with influenza. Bronchoscopy revealed diffuse pseudomembrane formation throughout the trachea and bilateral bronchi, which were nearly obstructed. In this case, it was helpful to perform bronchoscopy, protected brushing and tracheotomy immediately in order to avoid choking.
Yamazaki
Yoshitaka
Y
Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Hirai
Kazuya
K
Honda
Takayuki
T
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001980:Bronchi / Q000473:pathology; D001991:Bronchitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology*; D015377:Cilastatin / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D007251:Influenza, Human / Q000150:complications; D008297:Male; D008712:Methicillin / Q000494:pharmacology; D016106:Methicillin Resistance; D012128:Respiratory Distress Syndrome; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000502:physiology*; D014132:Trachea / Q000473:pathology; D014136:Tracheitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology*; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015377:Cilastatin; D014640:Vancomycin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination; D008712:Methicillin